| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceb27ac929cc189dd57782a690842dbf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264ceb88c3798d4a37bc99e33e6f24df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e464dcb706d867e72ebb0b992cde649f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1bd445fc4c566ac2d9d51ded7d0bc87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc3a1fdd2929cc85ecacd3b8c87aa4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c99f5cce5f2617e6298bb6b603a5081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8081360bbf5f966b3c7373380351e80f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86dab9aefa99def8d51085118280bb0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0788595ebbdbfb4a66bdeb983cf9fec |
| publicationDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9975875-B2 |
| titleOfInvention |
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity |
| abstract |
This invention relates to a compound of formula I: n n n n n n n n n n n n or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and β 2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138220-B1 |
| priorityDate |
2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |